Curtis L. Baysinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Curtis L. Baysinger has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Matthew S. Shotwell
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, United States
2 shared publications- Atanas G. Sivevski
Department of Anesthesiology, University Hospital of Gynecology and Obstetrics, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia
1 shared publication Borislava Pujic
Klinika za Ginekologiju I Akuserstvo, Klinickog Centra Vojvodine, Novi Sad, Serbia
1 shared publicationDafina Karadzova
Department of Anesthesiology, University Hospital of Gynecology and Obstetrics, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia
1 shared publicationFerne Braveman
Department of Anesthesiology, Yale University School of Medicine, New Haven, CT, United States
1 shared publicationIrena Aleksioska-Papestiev
Department of Anesthesiology, University Hospital of Gynecology and Obstetrics, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia
1 shared publication
Latest Publications
- Open Access
- 24 September 2020
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 1, 567810
Post Partum Death in a Patient Diagnosed With COVID-19
Background: There are few case reports describing maternal mortality and intensive care of the pregnant patient with COVID-19 infection. Case: A 27-year-old patient at 34 weeks of gestation was admitted for the evaluation of cough, fever, tachypnea, and oligohydramnios. The day of admission she underwent cesarean delivery for a non-reassuring fetal heart rate tracing. Over the next 6 days her clinical condition deteriorated, she developed multi organ system failure, and died despite aggressive supportive care. Conclusion: Although mortality related to COVID-19 in pregnancy has been rarely reported to date, we describe a case of progressive clinical deterioration postpartum despite aggressive supportive care. Management strategies specific for pregnant women have not been developed. In timing delivery, the obstetrician must consider the possibility that the inflammatory response associated with CD may increase the risk for multiorgan system failure in parturients with COVID-19 while recognizing that risks to the fetus may be higher in patients with COVID-19 than in other critically ill parturients. Vertical transmission of infection to the neonate did not occur in our case and has not been demonstrated in other pregnancies with COVID-19 disease.
- 24 September 2020
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 1, 567810
Open AccessPost Partum Death in a Patient Diagnosed With COVID-19
Background: There are few case reports describing maternal mortality and intensive care of the pregnant patient with COVID-19 infection. Case: A 27-year-old patient at 34 weeks of gestation was admitted for the evaluation of cough, fever, tachypnea, and oligohydramnios. The day of admission she underwent cesarean delivery for a non-reassuring fetal heart rate tracing. Over the next 6 days her clinical condition deteriorated, she developed multi organ system failure, and died despite aggressive supportive care. Conclusion: Although mortality related to COVID-19 in pregnancy has been rarely reported to date, we describe a case of progressive clinical deterioration postpartum despite aggressive supportive care. Management strategies specific for pregnant women have not been developed. In timing delivery, the obstetrician must consider the possibility that the inflammatory response associated with CD may increase the risk for multiorgan system failure in parturients with COVID-19 while recognizing that risks to the fetus may be higher in patients with COVID-19 than in other critically ill parturients. Vertical transmission of infection to the neonate did not occur in our case and has not been demonstrated in other pregnancies with COVID-19 disease.
- 16 November 2018
- Published by Springer Nature
- p. 193-195
Ethyl Alcohol Use
- 16 November 2018
- Published by Springer Nature
- p. 87-88
Benzodiazepine Use
- 16 November 2018
- Published by Springer Nature
- p. 105-106
Caffeine Use
- 16 November 2018
- Published by Springer Nature
- p. 107-108
Cannabis Use
- 16 November 2018
- Published by Springer Nature
- p. 141-143
Cocaine Use
- 16 November 2018
- Published by Springer Nature
- p. 21-23
Amphetamines and Other Stimulant Use
- 16 November 2018
- Published by Springer Nature
- p. 303-306
Illicit Drug Use and Substance Abuse
- 16 November 2018
- Published by Springer Nature
- p. 249-250
Hallucinogen Use